Altimmune Inc — Quarterly Cash Flow (NASDAQ:ALT) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Total assets 139.31 M157.26 M190.35 M218.45 M279.93 M Total liabilities 15.8 M15.1 M28.98 M32.85 M55.04 M Total equity 123.51 M142.16 M161.37 M185.6 M224.89 M Total liabilities & shareholders' equities 139.31 M157.26 M190.35 M218.45 M279.93 M Total debt ——14.33 M14.45 M34.29 M Net debt ——-168.77 M-196.33 M-239.17 M

뉴스

ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms

Altimmune Stock: Neutral Outlook With Big 2026 Catalysts

ALT Pemvidutide Explained: What Makes It Different in MASH

알티뮨, MASH 집중으로 H.C. Wainwright 목표 주가 상향

H.C. Wainwright raises Altimmune stock price target on MASH focus

Altimmune, Pemvidutide 잠재력 발표 (Barclays 컨퍼런스)

Altimmune at Barclays Conference: Advancing Pemvidutide’s Potential

Altimmune, MASH 치료 전략 발전 발표

Altimmune at Leerink Conference: Strategic Advances in MASH Treatment

알티뮨 CEO, 70,790달러 상당 자사주 매입

Altimmune CEO Durso buys $70,790 in shares

알티뮨 CFO Weaver, 2300만원 상당 주식 매입